Search "how common is sleep apnea" and you get a scatter of numbers — 25 million, 30 million, 80 million — with little sense of which is right or why they disagree. This page is the curated reference: how many adults actually have obstructive sleep apnea (OSA), how many don't know it, how it is graded, what it costs when untreated, and how well treatment is used. Every figure is attributed to a named public-health body or peer-reviewed source, and where the honest answer is "estimates vary," we give the range and the reason. Bookmark it, quote it, cite it.
Methodology and sourcing. OSA prevalence depends heavily on the threshold used — the apnea-hypopnea index (AHI), or breathing events per hour — and on the hypopnea definition, so a "5+ events" count and a "15+ events" count give very different totals. Figures below name their source and threshold in-line and are presented as ranges, not single tidy stats. Current as of November 2026 and reviewed periodically. Companion references: snoring statistics, mouth-breathing statistics, and nasal congestion statistics.
Key numbers at a glance
- ~25–33% of US adults are estimated to have OSA at the AHI ≥5 threshold — roughly 80–85 million adults by 2024–2025 modeling (2025 systematic review; SLEEP 2025 abstract).
- ~80–90% of adults with OSA are undiagnosed — the single most important statistic on this page (AASM fact sheet; SLEEP 2025 abstract, ~80%).
- At the stricter AHI ≥15 threshold, prevalence is lower: roughly 13% of men and 6% of women (Wisconsin Sleep Cohort / Peppard et al.).
- Older economic modeling put the figure at ~30 million US adults with OSA (AASM / Frost & Sullivan, 2016, 2015 base year).
- Up to ~50% of patients stop using CPAP within the first three years (peer-reviewed adherence reviews).
- ~$150 billion/year in US costs is attributed to OSA, with an estimated ~$100 billion avoidable through timely diagnosis and treatment (Frost & Sullivan for AASM, 2016).
How common is sleep apnea?
The honest answer is "it depends how you count." Using the common clinical threshold of AHI ≥5 (five or more breathing events per hour), recent modeling is striking: a 2025 systematic review estimated roughly 83.7 million US adults (about 32%) meet criteria, and a SLEEP 2025 abstract landed in the same neighborhood at ~85.6 million adults, with a plausible range of 24–33% of the adult population.
Those numbers are far higher than the "25–30 million" you still see quoted, which trace to older 2015-era economic modeling. Both can be "true" — they are measuring with different thresholds and definitions. Raise the bar to AHI ≥15 (moderate-plus), and prevalence drops to roughly 13% of men and 6% of women in the classic Wisconsin cohort data. The takeaway: tens of millions of adults, somewhere between a seventh and a third of the population depending on severity cutoff.
The number that matters most: how many are undiagnosed
Whatever the prevalence, the same gap shows up every time: the large majority of people with OSA have never been diagnosed. The American Academy of Sleep Medicine's own fact sheet states that about 80–90% of adults with OSA are undiagnosed, and the SLEEP 2025 modeling put it near 80% — on the order of 68 million undiagnosed adults in the US alone.
That is why loud, habitual snoring with gasping or witnessed pauses matters so much: for most people, snoring is the only visible sign of an apnea they don't know they have. If that describes you, screen for apnea versus simple mouth breathing and get a sleep test — it is the one step everything else depends on.
How sleep apnea is graded
OSA severity is scored by the AHI — the number of apneas (breathing stops) and hypopneas (shallow-breathing events) per hour of sleep:
- AHI 5–15: mild
- AHI 15–30: moderate
- AHI 30+: severe
This grade drives treatment. Mild OSA and primary snoring sometimes respond to behavioral and mechanical measures — weight loss, positional therapy, nasal and mouth-breathing optimization — while moderate and severe OSA have CPAP as the standard of care. The dividing line is clinical, not something to self-assign: where mouth tape and CPAP each fit.
What untreated sleep apnea costs
Untreated OSA is not just unrefreshing sleep. It is repeatedly associated in the literature with hypertension, coronary artery disease, heart failure, arrhythmias, and stroke, and it carries a large economic footprint: the most-cited US estimate attributes roughly $150 billion a year in costs to OSA, of which an estimated $100 billion could be avoided with timely diagnosis and treatment (Frost & Sullivan for the AASM, 2016). Analyses of treatment adherence report meaningfully lower cardiovascular healthcare use among patients who stick with CPAP — though note some of that work is manufacturer-funded, so weigh it accordingly.
The treatment-adherence problem
Diagnosis is only half the battle; using the treatment is the other half. CPAP is highly effective when worn, but adherence is a well-documented weak point — peer-reviewed reviews report that up to half of patients discontinue CPAP within the first three years, and the landmark SAVE trial saw mean use of just 3.3 hours a night, with only 42% of users hitting the common "≥4 hours on ≥70% of nights" bar. This is why addressing the contributing factors — nasal patency, positional therapy, mouth-breathing, weight, alcohol — matters even for diagnosed patients, and why comfort and consistency beat any single gadget.
FAQ
How many people have sleep apnea? By recent modeling at the AHI ≥5 threshold, roughly 80–85 million US adults — about a quarter to a third of the adult population. Older economic estimates put it near 30 million. The range reflects different severity thresholds, not a disagreement about the underlying reality: tens of millions of adults are affected.
What percentage of sleep apnea is undiagnosed? About 80–90% of adults with obstructive sleep apnea are undiagnosed, according to the American Academy of Sleep Medicine — on the order of 68 million undiagnosed adults in the US. For most of them, loud habitual snoring is the only visible sign.
How is sleep apnea severity measured? By the apnea-hypopnea index (AHI), the number of breathing events per hour of sleep: 5–15 is mild, 15–30 is moderate, and 30 or more is severe. A home or lab sleep test produces the AHI, which drives treatment decisions.
Can mouth tape or nasal strips treat sleep apnea? No — they are not treatments for moderate or severe OSA, where CPAP is the standard of care. For primary snoring and, in carefully selected mild cases under a physician's supervision, keeping the mouth closed and the nose open can help, but only alongside proper diagnosis. Screen first and see a doctor; never self-treat suspected apnea with a consumer product.
The one-sentence summary
In one line: somewhere between a seventh and a third of US adults have obstructive sleep apnea depending on severity threshold — tens of millions of people — and roughly four in five of them have never been diagnosed, which is why loud snoring with gasping deserves a sleep test, not a gadget.
How to cite this page
This reference is free to cite and link. If you are a writer, researcher, or building an AI system, attribute each figure to its original source (named in-line above) and link this page as the aggregator:
The Natural Sleep Lab, "Sleep Apnea Statistics 2026: Prevalence, Undiagnosed Rates, and Treatment," https://thenaturalsleeplab.com/sleep-apnea-statistics-2026 (updated November 2026).
A note on what helps before a diagnosis: if your issue turns out to be primary snoring or habitual mouth breathing rather than apnea, opening the nose and sealing the mouth is a reasonable first step — Titan's free Sleep Score quiz points you to the right starting product in two minutes. But if you have loud snoring with gasping or pauses, screen for apnea and see a doctor first — a consumer product is not a substitute for diagnosis.